MedPath

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

Not Applicable
Recruiting
Conditions
Parathyroid Cancer
Hypercalcemia
Parathyroid Adenoma
Primary Hyperparathyroidism
Parathyroid Neoplasms
Interventions
Device: PTeye
Registration Number
NCT05022641
Lead Sponsor
University of Michigan
Brief Summary

This study will see if the use of near infrared autofluorescence (NIRAF) detection with an FDA-cleared device 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during parathyroidectomy (PTx) procedures is better than a surgeon's detection alone. It compares risk-benefits and outcomes in PTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Primary hyperparathyroidism who will be undergoing parathyroid surgery
  • Persistent primary hyperparathyroidism after having undergone a failed prior parathyroid surgery who will be undergoing repeat parathyroid surgery
Read More
Exclusion Criteria
  • Pregnant women (Those patients who could potentially will receive preoperative pregnancy testing, as is standard before general anesthesia. Any patients with positive pregnancy test results will not be included in the study.)
  • Patients with concurrent parathyroid and thyroid disease that require total thyroidectomy
  • Patients with secondary or tertiary hyperparathyroidism
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PTeyePTeyeThe surgeon will use the PTeye as an intraoperative tool to identify if a suspect tissue is a parathyroid or not, during the parathyroid surgery.
Primary Outcome Measures
NameTimeMethod
Parathyroid hormone (PTH) levels6 months after surgery
Blood calcium levels6 months after surgery
Secondary Outcome Measures
NameTimeMethod
Percent of repeat surgeries due to high calciumup to 6 months

Repeat surgeries are documented as binary (yes or no)

Frequency of postoperative (within 30 days) Emergency Room visits or hospitalizationup to 30 days

Medical record review

Average number of minutes taken to identify first parathyroid glandImmediate. During PTx procedure

Duration taken to identify 1st parathyroid gland in PTx procedure - timed from skin incision to finding parathyroid gland in each participant.

Permanent histology - parathyroid tissue, cellularity, gland weightPermanent histology collected after report generated by pathologist (5-7 days)
Average number of minutes taken to identify last parathyroid glandImmediate. During PTx procedure

Duration taken to identify last parathyroid gland in PTx procedure - timed from skin incision to finding the last parathyroid gland in each participant.

Minutes taken for intraoperative parathyroid hormone (PTH) to normalizeImmediate. During PTx procedure.

Time taken for PTH to attain cure criteria or normalize - timed from skin incision until the PTH levels drops \> 50% of its baseline value and/or PTH drops \< 65 pg/ml or 6.9 pmol/L.

Number of patients who have had repeat parathyroidectomy (PTx) procedure6 months after PTx procedure

Number of patients with repeat PTx procedure performed after the current procedure

Number of frozen section analysis performed (by case)Collected immediately following surgery
Number of postsurgical complicationsup to 30 days

Medical record review

Duration of Surgery in minutesCollected immediately following surgery
Percent of frozen sections confirmed as parathyroid tissueFrozen results collected immediately after surgery.
Number of nights spent in the hospital after parathyroidectomy0-72 hours after PTx procedure.

Number of nights spent for postoperative recovery in the hospital after the surgical procedure.

Overall number of parathyroid glands identified.Time Frame: Immediate. During total thyroidectomy procedure.

Overall number of parathyroid glands identified (Experimental Group: Glands identified with naked eye + NIRAF; Control Group: Glands identified with naked eye)

Trial Locations

Locations (1)

The University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath